Class 3 medicines recall: AlfaD Capsules (Theramex) – Update – additional batch included
Class 3 medicines recall: AlfaD Capsules (Theramex) – Update – additional batch included
October 29, 2020
Drug Alert Number EL (20) A/50
This alert has been updated to include an additional batch detailed below:
AlfaD 0.25 microgram capsules PL 49876/0001
| Batch Number | Expiry Date | Pack Size | First Distributed |
| A04279A | 31 Jan 2022 | 30 | 26 Mar 2020 |
Class 3 Medicines recall: AlfaD Capsules (Theramex)
Drug alert number: EL (20) A/46
Date issued: 29th September 2020
The Medicines and Health products Regulatory Agency (MHRA) has issued a class 3 medicines recall for:
AlfaD Capsules (Theramex)
Theramex Ireland Ltd T/A Theramex HQ UK Ltd has informed us of an issue related to error in the decommissioning of the above batches. Upon decommissioning at the pharmacy and when scanning the serialised 2D code, the status of packs may report as ‘EXPORT’. Although there is no risk to product quality, any remaining stock should be quarantined and returned.
AlfaD 0.25 microgram capsules PL 49876/0001
| Batch Number | Expiry Date | Pack Size | First Distributed |
| A04285 | Apr 2022 | 30 | 15 Sep 2020 |
AlfaD 1 microgram capsules PL 49876/0003
| Batch Number | Expiry Date | Pack Size | First Distributed |
| 106389 | Aug 2022 | 30 | 15 Sep 2020 |
Advice for healthcare professionals
- Stop supplying the batches listed above immediately.
- Quarantine all remaining stock and return it to your supplier using your supplier’s approved process.
Full drug alert can be viewed here.
Company contacts for further information
For stock control enquiries please contact Theramex HQ UK Ltd Customer Services Team on 020 3962 5532
For medical information enquiries please contact Theramex HQ UK Ltd Medical Information Department on 033 3009 6795
Posted in: Dispensing & Supply
